• Home
  • NEW DAY MEDICINE
  • 1 (25) 2019
  • 49 -1 (25/2) 2019 — Artikova S.G, Sodikova D.T., — CHANGES OF QUANTITY OF ALT AND AST IN THE DISEASE OF HEART FAILURE AND ISCHEMIC HEART DISEASE

49 -1 (25/2) 2019 — Artikova S.G, Sodikova D.T., — CHANGES OF QUANTITY OF ALT AND AST IN THE DISEASE OF HEART FAILURE AND ISCHEMIC HEART DISEASE

CHANGES OF QUANTITY OF ALT AND AST IN THE DISEASE OF HEART FAILURE AND ISCHEMIC HEART DISEASE

Artikova S.G, Andijan State Medical Institute.

Sodikova D.T., Andijan State Medical Institute.

Khudoyarova N.K. Andijan State Medical Institute.

Resume,

Has a significant diagnostic value – myocardial infarction (in 80-100% of cases). AST begins to increase after 4­6 hours after the onset of pain syndrome or its equivalent, after 24-48 hours reaches its maximum value, and returns to normal after 4-7 days.

There is no significant diagnostic value – hepatitis, a deficiency of the right heart, hemolysis, damage to the muscles, kidneys, brain.

Alanine aminotransferase – (ALT) (Glutamic-pyruvic transaminase – GPT) It is contained mainly in the cytoplasm of the hepatic cells.

Key words: ALT, AST, ischemic, disease of heart failure.

First page

194

Last page

197

For citation: Artikova S.G, Sodikova D.T., Khudoyarova N.K. Changes of quantity of alt and ast in the disease of heart failure and ischemic heart disease//New Day in Medicine 1(25)2019 194-197 https://cutt.ly/7bFjwr9

List of References

  1. Aronov D.M., Lupanov V.P. Diagnosis and treatment of chronic coronary heart disease // Quality of life. The medicine. 2003; No. 2: 16-24.
  2. Burkov S.G. Current approaches to acid therapy diseases // breast cancer. 2007. – Volume 15. – № 6.
  3. Vasiliev Yu. V. Acid-dependent gastrointestinal diseases and ischemic heart disease // attending physician. – 2006. – № 1. – p. 50-55.
  4. Vertkin A.L., Shamuilova M.M., Naumov A.V., Ivanov V.S., Semenov P. A., Goruleva E. I., Mendel O. I. Acute mucosal lesions shell of the upper gastrointestinal tract in the general medical practice // Russian Medical Journal; Volume 11; No. 1; 2009; p. 1-5.
  5. Vertkin A. L., Vovk E. I., Naumov A. V., Ivanov V. S., Otpuschenko A. V., Semenova P. A. Treatment and prevention of mucosal lesions of the gastrointestinal tract in therapeutic practice // “Clinical perspectives of gastroenterology, hepatology “, 2009, №1, p. 35­41.
  6. Vovk E.I. Functional and organic dyspepsia: “cross”strategies for diagnosis and treatment in general practice // The attending physician. Gastroenterology 2012. № 9.
  7. Gelfand B. R., Guryanov A. V., Martynov A. N., Popov T. V., ShipilovaO. S. Prevention of stress – damage to the gastrointestinal tract in critically ill patients // Consilium medicum. 2005. Tom 7, No. 6. P. 464-67
  8. Golikov Z.N. Erosive and ulcerative lesions of the stomach and duodenal ulcer in patients with cardiovascular pathology, receiving disaggregant therapy: diagnosis, treatment and prevention.
  9. Gubergrits NB, Agapova N.G. Abdominal Ischemic Syndrome // Doktor. – 2004. – № 3. – p. 7-11.
  10. Evseev M.A. Prevention of stress erosive and ulcerative lesions of the gastroduodenal zone in patients in critical States // Ros. Honey. Journal 2008 -T. 16, No. 29. From 2012-2019.
  11. Zaratyants OV, Kolobov S.V., N.I. Polyanka, Khokhlova E.E. Sharp erosive and ulcerative bleeding in patients with therapeutic and neurological profile // Sat. mes. Report VIII Moscow Assembly “Health Capital”. – M., 2009. – P.256-257
  12. Zvenigorodskaya L.A., Potapova V.B. Features of peptic ulcer in persons with concomitant ischemic heart disease // Therapeutic archive. 1998. № 2. S. 9-13.

file

download